A new drug delivery system has been developed that can target specific cells in the liver, potentially leading to better treatments for liver diseases such as hepatitis and cirrhosis. The nanogel-based drug carrier developed by researchers at the University of Tokyo has been found to reverse fibrosis, a process in which liver cells become scarred and the organ’s function is impaired. The nanogel is a polymer made up of molecules that can self-assemble and form a gel. This gel is then able to encapsulate drugs and be tailored to target specific cells. The researchers tested the nanogel out on mice with liver fibrosis, and found that the drug-loaded nanogel was able to reverse the fibrosis and restore normal liver function. This new technology could lead to targeted treatments for liver diseases, offering patients a more effective and safer alternative.

Read Full Article Here

source: Phys.org